IBRX Lawsuit Alleges Company Allegedly Violated FDA Drug Rules - ImmunityBio Investors Face Losses Following Company Allegedly Violated FDA Drug Rules: SueWallSt
Go back to IBRX Lawsuit Alleges Company Allegedly Violated FDA Drug Rules - ImmunityBio Investors Face Losses Following Company Allegedly Violated FDA Drug Rules: SueWallSt| (NASDAQ: IBRX) | Delayed: 7.22 -0.14 (1.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.36 | 52 Week High | $ | |||
| Open | $7.49 | 52 Week Low | $ | |||
| Day High | $7.55 | P/E | N/A | |||
| Day Low | $7.17 | EPS | $ | |||
| Volume | 9,870,259 | |||||
